Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,737

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Bioactive peptides: Production and functionality

Korhonen, Hannu, Pihlanto, Anne·2006·International Dairy Journal
DOI 10.1016/j.idairyj.2005.10.012
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.idairyj.2005.10.012

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 122

  1. Addeo, 1992, Characterization of the 12% trichloroacetic acid-insoluble oligopeptides of Parmigiano–Reggiano cheese, Journal of Dairy Research, 59, 401, 10.1017/S0022029900030673 · DOI
  2. Ashar, 2004, Fermented milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects, Milchwissenschaft, 59, 363
  3. Bordenave, 1999, Continuous hydrolysis of goat whey in an ultrafiltration reactor: Generation of alpha-lactorphin, Preparatory Biochemistry and Biotechnology, 29, 189, 10.1080/10826069908544890 · doi:10.1080/10826069908544890
  4. Bouhallab, 2004, Biopeptides of milk: Caseinophosphopeptides and mineral bioavailability, Reproduction, Nutrition & Development, 44, 493, 10.1051/rnd:2004053 · doi:10.1051/rnd:2004053
  5. Bouhallab, 2002, Journal of Agricultural and Food Chemistry, 50, 7127, 10.1021/jf025554v · DOI
  6. Bouhallab, 1995, Continuous hydrolysis of caseinomacropeptide in a membrane reactor: Kinetic study and gram-scale production of antithrombotic peptides, Lait, 75, 251, 10.1051/lait:1995317 · DOI
  7. Brantl, 1979, Novel opioid peptides derived from casein (β-casomorphins) I. Isolation from bovine casein peptone, Hoppe-Seyler′s Zeitschrift für Physiologie und Chemie, 360, 1211, 10.1515/bchm2.1979.360.2.1211 · DOI · Paper page
  8. Brody, 2000, Biological activities of bovine glycomacropeptide, British Journal of Nutrition, 84, S39, 10.1017/S0007114500002233 · DOI · Paper page
  9. Chabance, 1995, Characterization of an antithrombotic peptide from κ-casein in newborn plasma after milk ingestion, British Journal of Nutrition, 73, 583, 10.1079/BJN19950060 · DOI
  10. Clare, 2003, Biodefense properties of milk: The role of antimicrobial proteins and peptides, Current Pharmaceutical Design, 9, 1239, 10.2174/1381612033454874 · DOI · Paper page
  11. DeSilva, 2003, Isolation procedures for functional dairy components—novel approaches to meeting the challenges, Australian Journal of Dairy Technology, 58, 148
  12. Ellegård, 1999, Process scale chromatographic isolation, characterization and identification of tryptic bioactive casein phosphopeptides, International Dairy Journal, 9, 639, 10.1016/S0958-6946(99)00135-1 · DOI
  13. Fiat, 1993, Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities, Journal of Dairy Science, 76, 301, 10.3168/jds.S0022-0302(93)77351-8 · DOI · Paper page
  14. FitzGerald, 1998, Potential uses of caseinophosphopeptides, International Dairy Journal, 8, 451, 10.1016/S0958-6946(98)00068-5 · DOI · Paper page
  15. FitzGerald, R. J., Meisel, H. (2003). Milk protein hydrolysates and bioactive peptides. In: P.F. Fox, & P.L.H. McSweeney (Eds.), Advanced dairy chemistry, Vol. 1: Proteins (3rd ed.) (pp. 675–698). New York, NY, USA: Kluwer Academic/Plenum Publishers.
  16. FitzGerald, 2004, Hypotensive peptides from milk proteins, Journal of Nutrition, 134, 980S, 10.1093/jn/134.4.980S · DOI · Paper page
  17. Floris, 2003, Antibacterial and antiviral effects of milk proteins and derivatives there of, Current Pharmaceutical Design, 9, 1257, 10.2174/1381612033454810 · DOI · Paper page
  18. Fosset, 2002, Peptide fragments released from Phe-caseinomacropeptide in vivo in the rat, Peptides, 23, 1773, 10.1016/S0196-9781(02)00134-1 · DOI
  19. Fuglsang, 2003, Characterization of new milk-derived inhibitors of angiotensin converting enzyme in vitro and in vivo, Journal of Enzyme Inhibitors and Medical Chemistry, 18, 407, 10.1080/1475636031000138723 · DOI
  20. Fuglsang, 2003, Lactic acid bacteria: Inhibition of angiotensin converting enzyme in vitro and in vivo, Antonie van Leeuwenhoek, 83, 27, 10.1023/A:1022993905778 · DOI
  21. Gauthier, 1996, Use of ultrafiltration for the preparation of enzymatic hydrolysates from milk proteins, IDF Bulletin, 311, 31
  22. Gill, 2000, Immunoregulatory peptides in bovine milk, British Journal of Nutrition, 84, S111, 10.1017/S0007114500002336 · DOI · Paper page
  23. Gobbetti, 2000, Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4, Applied and Environmental Microbiology, 66, 3898, 10.1128/AEM.66.9.3898-3904.2000 · DOI · Paper page
  24. Gobbetti, 2004, Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides, International Journal of Dairy Technology, 57, 172, 10.1111/j.1471-0307.2004.00139.x · DOI · Paper page
  25. Gobbetti, 2002, Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing, Critical Reviews in Food Science and Nutrition, 42, 223, 10.1080/10408690290825538 · DOI · Paper page
  26. Gomez-Ruiz, 2002, Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures, International Dairy Journal, 12, 697, 10.1016/S0958-6946(02)00059-6 · DOI · Paper page
  27. Gustafson, 2001, Appetite is not influenced by a unique milk peptide: Caseinomacropeptide (CMP), Appetite, 36, 157, 10.1006/appe.2000.0392 · DOI
  28. Hansen, 1996, The effect of casein phosphopeptides on zinc and calcium absorption from high phytate infant diets assessed in rat pups and caco-2 cells, Pediatric Research, 40, 547, 10.1203/00006450-199610000-00006 · DOI
  29. Hata, 1996, A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, American Journal of Clinical Nutrition, 64, 767, 10.1093/ajcn/64.5.767 · DOI · Paper page
  30. Hernández-Ledesma, 2004, Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion, Journal of Agricultural and Food Chemistry, 52, 1504, 10.1021/jf034997b · DOI
  31. Hernández-Ledesma, 2004, Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas, International Dairy Journal, 14, 889, 10.1016/j.idairyj.2004.02.011 · DOI
  32. Ijäs, 2004, Antihypertensive opioid-like milk peptide α-lactorphin: Lack of effect on behavioural tests in mice, International Dairy Journal, 14, 201, 10.1016/j.idairyj.2003.08.002 · DOI
  33. Kilara, 2003, Peptides from milk proteins and their properties, Critical Reviews in Food Science and Nutrition, 43, 607, 10.1080/10408690390251138 · DOI
  34. Kim, 1999, Novel angiotensin-I-converting enzyme inhibitory peptides derived from recombinant human αs1-casein expressed in Escherichia coli, Journal of Dairy Research, 66, 431, 10.1017/S0022029999003556 · DOI
  35. Kitts, 2003, Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery, Current Pharmaceutical Design, 9, 1309, 10.2174/1381612033454883 · DOI · Paper page
  36. Korhonen, 2002, Technology options for new nutritional concepts, International Journal of Dairy Technology, 55, 79, 10.1046/j.1471-0307.2002.00050.x · doi:10.1046/j.1471-0307.2002.00050.x
  37. Korhonen, 2003, Food-derived bioactive peptides—opportunities for designing future foods, Current Pharmaceutical Design, 9, 1297, 10.2174/1381612033454892 · DOI · Paper page
  38. Korhonen, 2003, Bioactive peptides: Novel applications for milk proteins, Applied Biotechnology, Food Science and Policy, 1, 133
  39. Korhonen, 2003, Bioactive peptides: New challenges and opportunities for the dairy industry, Australian Journal of Dairy Technology, 58, 129
  40. Korhonen, 2001, Milk protein-derived bioactive peptides—novel opportunities for health promotion, IDF Bulletin, 363, 17
  41. Korhonen, 1998, Impact of processing on bioactive proteins and peptides, Trends in Food Science and Technology, 9, 307, 10.1016/S0924-2244(98)00054-5 · DOI · Paper page
  42. Kudoh, 2001, Antioxidative peptide from milk fermented with Lactobacillus delbrueckii subsp. bulgaricus IFO13953, Journal of the Japanese Society of Food Science, 48, 44, 10.3136/nskkk.48.44 · DOI
  43. Lahov, 1996, Antibacterial and immunostimulating casein-derived substances from milk: Casecidin, isracidin, peptides, Food Chemical Toxicology, 34, 131, 10.1016/0278-6915(95)00097-6 · DOI · Paper page
  44. Li, 2004, Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophagelike cells, U937, Journal of Agricultural and Food Chemistry, 52, 2704, 10.1021/jf0355102 · DOI
  45. Li, 2004, Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects, Nutrition Research, 24, 469, 10.1016/S0271-5317(04)00058-2 · DOI
  46. Maeno, 1996, Isolation of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790, Journal of Dairy Science, 79, 1316, 10.3168/jds.S0022-0302(96)76487-1 · DOI · Paper page
  47. Maes, 2004, Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells, Regulatory Peptides, 118, 105, 10.1016/j.regpep.2003.11.005 · DOI
  48. Manso, 2003, Angiotensin I converting enzyme-inhibitory activity of bovine; ovine; and caprine kappa-casein macropeptides and their tryptic hydrolysates, Journal of Food Protection, 66, 1686, 10.4315/0362-028X-66.9.1686 · DOI
  49. Manso, 2004, κ-Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses, Food Reviews International, 20, 329, 10.1081/FRI-200033456 · DOI
  50. Martin-Orue, 1999, Tryptic hydrolysis of κ-caseinomacropeptide: Control of the enzymatic reaction in a continuous membrane reactor, Enzyme Microbiology and Technology, 24, 173, 10.1016/S0141-0229(98)00100-8 · DOI
  51. Masuda, 1996, Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats, Journal of Nutrition, 126, 3063, 10.1093/jn/126.12.3063 · DOI · Paper page
  52. McCann, 2005, Isolation and characterisation of antibacterial peptides derived from the f(164–207) region of bovine αs2-casein, International Dairy Journal, 15, 133, 10.1016/j.idairyj.2004.06.008 · DOI
  53. Mehra, 2004, Whey protein fractionation using cascade membrane filtration, IDF Bulletin, 389, 40
  54. Meisel, 1998, Overview on milk protein-derived peptides, International Dairy Journal, 8, 363, 10.1016/S0958-6946(98)00059-4 · DOI · Paper page
  55. Meisel, 2001, Bioactive peptides from milk proteins: A perspective for consumers and producers, Australian Journal of Dairy Technology, 56, 83
  56. Meisel, 2004, Multifunctional peptides encrypted in milk proteins, BioFactors, 21, 55, 10.1002/biof.552210111 · DOI · Paper page
  57. Meisel, 2000, Opioid peptides encrypted in intact milk protein sequences, British Journal of Nutrition, 84, 27, 10.1017/S000711450000221X · DOI · Paper page
  58. Meisel, 2003, Detection of caseinophosphopeptides in the distal ileostomy fluid of human subjects, British Journal of Nutrition, 89, 351, 10.1079/BJN2002803 · DOI
  59. Meisel, 1997, ACE-inhibitory activities in milk products, Milchwissenschaft, 52, 307
  60. Mellander, 1950, The physiological importance of the casein phosphopeptide calcium salts II. Peroral calcium dosage of infants, Acta of the Society of Medicine of Uppsala, 55, 247
  61. Migliore-Samour, 1988, Casein prohormone with an immunomodulating role for the newborn, Experientia, 44, 188, 10.1007/BF01941703 · DOI
  62. Mizuno, 2004, Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease, Journal of Dairy Science, 87, 3183, 10.3168/jds.S0022-0302(04)73453-0 · DOI
  63. Mizushima, 2004, Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men, American Journal of Hypertension, 17, 701, 10.1016/j.amjhyper.2004.03.674 · DOI
  64. Monnai, 1998, Immunomodificatory effect of dietary bovine κ-caseinoglycopeptide on serum antibody levels and proliferative responses of lymphocytes in mice, Milchwissenschaft, 53, 129
  65. Muehlenkamp, 1996, β-casomorphins: Analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. cremoris, Journal of Dairy Science, 79, 20, 10.3168/jds.S0022-0302(96)76329-4 · DOI
  66. Mullally, 1997, Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin, FEBS Letters, 402, 99, 10.1016/S0014-5793(96)01503-7 · DOI · Paper page
  67. Nagaoka, 2001, Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin, Biochemical and Biophysical Research Communications, 218, 11, 10.1006/bbrc.2001.4298 · DOI · Paper page
  68. Nakamura, 1995, Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk, Journal of Dairy Science, 78, 777, 10.3168/jds.S0022-0302(95)76689-9 · DOI · Paper page
  69. Nakamura, 1995, Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme, Journal of Dairy Science, 78, 1253, 10.3168/jds.S0022-0302(95)76745-5 · DOI · Paper page
  70. Nurminen, 2000, α-lactorphin lowers blood pressure via radiotelemetry in normotensive and spontaneously hypertensive rats, Life Sciences, 66, 1535, 10.1016/S0024-3205(00)00471-9 · DOI · Paper page
  71. O`Donnell, 2004, Milk proteomics, International Dairy Journal, 14, 1013, 10.1016/j.idairyj.2004.04.004 · DOI
  72. Otani, 2000, The immunoenhancing property of dietary casein phosphopeptide preparation in mice, Food and Agricultural Immunology, 12, 165, 10.1080/095401000404102 · DOI
  73. Pan, 2004, Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004, Food Chemistry, 91, 123, 10.1016/j.foodchem.2004.05.055 · DOI
  74. Parrot, 2003, In vitro study on digestion of peptides in Emmental cheese: Analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides, Nahrung, 47, 87, 10.1002/food.200390032 · DOI
  75. Pellegrini, 2003, Antimicrobial peptides from food proteins, Current Pharmaceutical Design, 9, 1225, 10.2174/1381612033454865 · DOI
  76. Perea, 1996, Continuous hydrolysis of whey proteins in a membrane recycle reactor, Enzyme Microbiology and Technology, 18, 29, 10.1016/0141-0229(96)00046-4 · DOI
  77. Pérès, 1999, Mechanisms of absorption of caseinophosphopeptide bound iron, Journal of Nutritional Biochemistry, 10, 215, 10.1016/S0955-2863(98)00101-6 · doi:10.1016/s0955-2863(98)00101-6
  78. Perpetuo, 2003, Biochemical and pharmacological aspects of two bradykinin-potentiating peptides from tryptic hydrolysis of casein, Journal of Protein Chemistry, 22, 601, 10.1023/B:JOPC.0000008724.98339.ff · DOI
  79. Pihlanto, 2003, Bioactive peptides and proteins, Vol. 47, 175
  80. Pihlanto-Leppälä, 1994, Opioid peptides produced by in vitro proteolysis of bovine caseins, International Dairy Journal, 4, 291, 10.1016/0958-6946(94)90028-0 · DOI
  81. Pihlanto-Leppälä, 1996, Opioid whey protein peptides obtained by membrane filtration, IDF Bulletin, 311, 36
  82. Pihlanto-Leppälä, 2000, Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides, Journal of Dairy Research, 67, 53, 10.1017/S0022029999003982 · DOI · Paper page
  83. Pihlanto-Leppälä, 1998, Angiotensin I-converting enzyme inhibitory peptides derived from bovine milk proteins, International Dairy Journal, 8, 325, 10.1016/S0958-6946(98)00048-X · DOI · Paper page
  84. Recio, 2000, Bioactive peptides from food proteins: A new isolation method, Agro-Food-Industry Hi-Tech, 2, 9
  85. Recio, 1999, Two ion-exchange methods for the isolation of antibacterial peptides from lactoferrin—in situ enzymatic hydrolysis on an ion-exchange membrane, Journal of Chromatography, 831, 191, 10.1016/S0021-9673(98)00950-9 · DOI
  86. Righetti, 1997, Continuous enzymatic hydrolysis of beta-casein and isoelectric collection of some of the biologically active peptides in an electric field, Biotechnology Progress, 13, 258, 10.1021/bp970019e · doi:10.1021/bp970019e
  87. Rival, 2001, Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition, Journal of Agricultural and Food Chemistry, 4, 295, 10.1021/jf0003911 · DOI · Paper page
  88. Rival, 2001, Caseins and casein hydrolysates. 1. Lipoxygenase inhibitory properties, Journal of Agricultural and Food Chemistry, 4, 287, 10.1021/jf000392t · DOI
  89. Rokka, 1997, Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT-milk, Milchwissenschaft, 52, 675
  90. Roudot-Algaron, 1994, Phosphopeptides from Comté cheese: Nature and origin, Journal of Food Science, 59, 544, 10.1111/j.1365-2621.1994.tb05558.x · DOI
  91. Ryhänen, 2001, A new type of ripened; low-fat cheese with bioactive properties, International Dairy Journal, 11, 441, 10.1016/S0958-6946(01)00079-6 · DOI · Paper page
  92. Sabikhi, 2001, Qualitative and quantative analysis of β-casomorphins in Edam cheese, Milchwissenschaft, 56, 198
  93. Saito, 2000, Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese, Journal of Dairy Science, 83, 1434, 10.3168/jds.S0022-0302(00)75013-2 · DOI · Paper page
  94. Satake, 2002, Transepithelial transport of a bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers, Bioscience, Biotechnology and Biochemistry, 66, 378, 10.1271/bbb.66.378 · DOI · Paper page
  95. Schanbacher, 1998, Milk borne bioactive peptides, International Dairy Journal, 8, 393, 10.1016/S0958-6946(98)00062-4 · DOI
  96. Scholz-Ahrens, 2000, Effects of bioactive substance in milk on mineral and trace element metabolism with special reference to casein phosphopeptides, British Journal of Nutrition, 84, S147, 10.1017/S0007114500002373 · DOI
  97. Sekiya, 1992, Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers, Journal of Japanese Society of Nutrition and Food Science, 45, 513, 10.4327/jsnfs.45.513 · DOI
  98. Seppo, 2003, A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects, American Journal of Clinical Nutrition, 77, 326, 10.1093/ajcn/77.2.326 · DOI · Paper page
  99. Seppo, 2002, The effect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension—a pilot study on humans, Milchwissenschaft, 57, 124
  100. Shimizu, 2004, Food-derived peptides and intestinal functions, BioFactors, 21, 43, 10.1002/biof.552210109 · DOI
  101. Silva, 2005, Caseins as source of bioactive peptides, International Dairy Journal, 15, 1, 10.1016/j.idairyj.2004.04.009 · DOI · Paper page
  102. Singh, 1997, Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of Cheddar cheese, Journal of Dairy Research, 64, 433, 10.1017/S0022029997002227 · DOI · Paper page
  103. Sipola, 2002, Effect of long-term intake of milk products on blood pressure in hypertensive rats, Journal of Dairy Research, 69, 103, 10.1017/S002202990100526X · DOI · Paper page
  104. Sipola, 2001, Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats, Journal of Physiology and Pharmacology, 52, 745
  105. Smacchi, 1998, Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria; Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme, Enzyme Microbiology and Technology, 22, 687, 10.1016/S0141-0229(97)00261-5 · DOI
  106. Suetsuna, 2000, Isolation and characterization of free radical scavenging activities peptides derived from casein, Journal of Nutrition and Biochemistry, 11, 128, 10.1016/S0955-2863(99)00083-2 · DOI · Paper page
  107. Sütas, 1996, Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes, Scandinavian Journal of Immunology, 43, 687, 10.1046/j.1365-3083.1996.d01-258.x · DOI · Paper page
  108. Sütas, 1996, Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes, Journal of Allergy and Clinical Immunology, 98, 216, 10.1016/S0091-6749(96)70245-2 · DOI · Paper page
  109. Takano, 1998, Milk derived peptides and hypertension reduction, International Dairy Journal, 8, 375, 10.1016/S0958-6946(98)00060-0 · DOI
  110. Takano, 2002, Anti-hypertensive activity of fermented dairy products containing biogenic peptides, Antonie van Leeuwenhoek, 82, 333, 10.1023/A:1020600119907 · DOI
  111. Tauzin, 2002, Angiotensin I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine αs2-casein, FEBS Letters, 531, 369, 10.1016/S0014-5793(02)03576-7 · DOI
  112. Teschemacher, 2003, Opioid receptor ligands derived from food proteins, Current Pharmaceutical Design, 9, 1331, 10.2174/1381612033454856 · DOI
  113. Tolkach, 2004, Fractionation of whey proteins and peptides by means of membrane techniques in connection with chemical and physical pretreatments, IDF Bulletin, 389, 20
  114. Turgeon, 1990, Whey peptide fractions obtained with a two-step ultrafiltration process: Production and characterization, Journal of Food Science, 55, 106, 10.1111/j.1365-2621.1990.tb06028.x · DOI
  115. Vermeirssen, 2002, Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer, Journal of Peptide Science, 8, 95, 10.1002/psc.371 · DOI
  116. Vermeirssen, 2004, Bioavailability of angiotensin I-converting enzyme inhibitory peptides, British Journal of Nutrition, 92, 357, 10.1079/BJN20041189 · DOI · Paper page
  117. Wakabayashi, 2003, Lactoferricin derived from milk protein lactoferrin, Current Pharmaceutical Design, 9, 1277, 10.2174/1381612033454829 · DOI · Paper page
  118. Walsh, 2004, In vitro generation and stability of the lactokinin β-lactoglobulin fragment (142–148), Journal of Dairy Science, 87, 3845, 10.3168/jds.S0022-0302(04)73524-9 · DOI
  119. Williams, 2002, Factors affecting the activity of enzymes involved in peptide and amino acid catabolism in non-starter lactic acid bacteria isolated from Cheddar cheese, International Dairy Journal, 12, 841, 10.1016/S0958-6946(02)00063-8 · DOI
  120. Yamamoto, 1999, Antihypertensive peptides derived from milk proteins, Nahrung, 43, 159, 10.1002/(SICI)1521-3803(19990601)43:3<159::AID-FOOD159>3.0.CO;2-R · DOI
  121. Yamamoto, 2003, Biogenic peptides and their potential use, Current Pharmaceutical Design, 9, 1345, 10.2174/1381612033454801 · DOI · Paper page
  122. Yvon, 1994, Effects of caseinomacropeptide (CMP) on digestion regulation, Reproduction, Nutrition & Development, 34, 527, 10.1051/rnd:19940602 · DOI

Cited by

See all 1,737

Metadata

Authors
Korhonen, H., & Pihlanto, A.
Venue
International Dairy Journal
Publisher
Elsevier BV
Published
2006-09
Volume
16
Issue
9
Pages
945-960
ISSN
0958-6946 (ISSN-L)
DOI
10.1016/j.idairyj.2005.10.012
OpenAlex
W2093974041
Cited by
1,737
References
14
FWCI
12.40
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioactive peptides: Production and functionality. https://app.cochat.ai/papers/10.1016/j.idairyj.2005.10.012
The paper
Korhonen, H., & Pihlanto, A. (2006). Bioactive peptides: Production and functionality. International Dairy Journal. https://doi.org/10.1016/j.idairyj.2005.10.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.